Clinical Trials Browser

OTHER × Esophageal × nimotuzumab × Clear all

NCT02591784 2022-03-17

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal